Miscellaneous Malignancies | Norton Healthcare

Indication: Miscellaneous Malignancies

An Open-Label Study of ALPN-202 in Subjects with Advanced Malignancies (NEON-1)

Sub-indication: Miscellaneous Malignancies

Drug Study

Principal Investigator: Jaspreet Grewal, M.D.
Norton Cancer Institute

Sponsor: Alpine Immune Sciences, Inc.

Learn more at ClinicalTrials.gov

Email for more information: MISC-NCIResearch@Nortonhealthcare.org

Search our entire site.

Schedule an Appointment

Select an appointment date and time from available spots listed below.